Refactor Capital

Refactor Capital, founded in 2016 by Zal Bilimoria, is a seed-stage venture capital firm based in Burlingame, California. The fund primarily focuses on bio, climate, and hard tech innovations, aiming to support startups that tackle fundamental human and planetary health challenges. Notable investments include Solugen, Astranis, and Notable Labs, showcasing their dedication to transformative technologies in fields like sustainable chemicals, space, and healthcare. Refactor Capital typically leads or co-leads seed rounds, with investment amounts ranging from $1M to $2M. The firm values quick decision-making and close founder relationships, providing extensive support beyond capital, such as CFO services, communications training, and mental fitness resources. This hands-on approach is integral to their strategy, ensuring startups receive comprehensive guidance and resources. Geographically, Refactor Capital focuses on the U.S., with a significant portion of their portfolio companies based in California. They prefer to invest in startups that demonstrate clear potential to disrupt and innovate within heavily regulated industries, making technologies more accessible and efficient. Zal Bilimoria, the solo partner of Refactor Capital, brings a wealth of experience from his time at Andreessen Horowitz and major tech companies like Google, Netflix, and LinkedIn. His leadership and deep industry connections make Refactor Capital a formidable player in the early-stage investment landscape.